Wolfe Research Initiates Coverage on Beta Bionics (NASDAQ:BBNX)
Investment analysts at Wolfe Research began coverage on shares of Beta Bionics (NASDAQ:BBNX – Get Free Report) in a research note issued on Friday, Marketbeat reports. The brokerage set an “outperform” rating and a $20.00 price target on the stock. Wolfe Research’s price objective would indicate a potential upside of 16.28% from the stock’s current […]
Investment analysts at Wolfe Research began coverage on shares of Beta Bionics (NASDAQ:BBNX – Get Free Report) in a research note issued on Friday, Marketbeat reports. The brokerage set an “outperform” rating and a $20.00 price target on the stock. Wolfe Research’s price objective would indicate a potential upside of 16.28% from the stock’s current […]
